Dr Jesse Dawson

  • Reader (Institute of Cardiovascular and Medical Sciences)
  • Associate (School of Medicine)

Research interests

My research is focussed on new methods of preventing and managing acute stroke. In particular, I aim to bridge the pre-clinical / clinical gap by identifying biomarkers for use in stroke research and to improve the measurements we use in clinical trials, thereby facilitating the evaluation of novel therapies.

I have received recently received research funding to advance Robotic mediated measurement and rehabilitation of limb function after stroke, imaging based biomarkers in high risk patients and have begun building a comprehensive biobank of well phenotyped stroke sufferers. I am deputy chair and outcomes manager for the endpoints committee for the large NIH funded CLEAR III IVH study, Vice Chair of an NHS Research Ethics Committee and Director of Clinical Pharmacology and Therapeutic teaching at the University of Glasgow Medical School.

Research:

Clinical Trials:

Member:

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR 3)
    National Institute of Health
    2014 - 2015
     
  • RATULS: Robot assisted training for the upper limb after stroke.
    Health Technology Assessment
    2014 - 2019
     
  • A new urinary biomarker for stroke
    Medical Research Council
    2014 - 2015
     
  • Xanthine oxidase inhibition for improvement of Long-term Outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST)
    Stroke Association
    2014 - 2019
     
  • MISTIE III
    National Institute of Health
    2013 - 2014
     
  • Robotic Therapy Early After Stroke Events (RTEASE).
    Chest, Heart & Stroke, Scotland
    2012 - 2015
     
  • EuroHyp
    European Commission
    2012 - 2017
     
  • Proteomics and Metabolomics to Help Understand and Improve Recovery in Stroke Survivors.
    The RS Macdonald Charitable Trust
    2012 - 2013
     
  • The iomarkers in Stroke Programme; Detecting, Understanding, and Predicting Outcome After Stroke (ISSF Catalyst Fund)
    Wellcome Trust
    2011 - 2014
     
  • Allopurinol and Cerebral Ischaemia; Developing a Model for a Future Clinical Trial
    NHS Greater Glasgow and Clyde
    2011 - 2013
     
  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III
    National Institute of Health
    2009 - 2013
     
  • The effect of allopurinol on carotid intima-media thickness and markers of endothelial function in patients with recent stroke - a pilot study
    The Stroke Association
    2009 - 2012
     
  • The Impact of Intraventricular Haemorrhage on Functional Outcomes and Economic Cost of Stroke.
    The Stroke Association
    2009 - 2010
     
  • Central adjudication of modified Rankin scale disability assessments in acute stroke trials
    Scottish Executive Health Department
    2009 - 2010
     
  • Endowment Fellowship
    NHS Greater Glasgow & Clyde West Research Endowment Fund
    2007 - 2008
     
  • Aspirin resistance and microemboli - towards targeted antiplatelet treatment
    Chest, Heart & Stroke, Scotland
    2006 - 2008
     

Publications

List by: Type | Date

Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2004
Number of items: 66.

2015

Fulton, R. L., Walters, M. R., Morton, R., Touyz, R. M., Dominiczak, A. F., Morrison, D. S., Padmanabhan, S., Meredith, P. A., McInnes, G. T., and Dawson, J. (2015) Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension, (doi:10.1161/HYPERTENSIONAHA.114.04945) (Early Online Publication)

2014

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J., Macfarlane, P. W., McArthur, K., Langhorne, P., and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi:10.1161/STROKEAHA.114.005405)

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K.R., Tyrrell, P.J., and Smith, C.J. (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke, 45(2), pp. 520-526. (doi:10.1161/STROKEAHA.113.003433)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9), pp. 563-570. (doi:10.1093/eurheartj/eht539)

2013

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Goodfellow, J.A., Dawson, J., and Quinn, T.J. (2013) Management of blood pressure in acute stroke. Expert Review of Neurotherapeutics, 13(8), pp. 911-923. (doi:10.1586/14737175.2013.814964)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1), pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Ziai, W. C. et al. (2013) A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). International Journal of Stroke, 9(4), pp. 536-542. (doi:10.1111/ijs.12097)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Marshall, S., Fearon, P., Dawson, J., and Quinn, T.J. (2013) Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 13(1), pp. 29-42. (doi:10.1586/ERP.12.79)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7), pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Higgins, P., Macfarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi:10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

2012

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4), pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5), e35879. (doi:10.1371/journal.pone.0035879)

2011

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6), e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4), pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Dawson, J., and McArthur, K. (2011) Under the weather with stroke before more data emerge - reply. International Journal of Stroke, 6(1), p. 90. (doi:10.1111/j.1747-4949.2010.00546.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi:10.1038/nnano.2011.5)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342, d1938. (doi:10.1136/bmj.d1938)

Stewart, K., Walters, M., and Dawson, J. (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Heart, 97(7), pp. 585-586. (doi:10.1136/hrt.2010.219717)

2010

Harrison, J.K., Sloan, B., Dawson, J., Lees, K.R., and Morrison, D.S. (2010) The ABCD and ABCD2 as predictors of stroke in transient ischemic attack clinic outpatients: a retrospective cohort study over 14 years. Quarterly Journal of Medicine, 103(9), pp. 679-685. (doi:10.1093/qjmed/hcq108)

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3), pp. 18-21.

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2), pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36), pp. 4578-4586. (doi:10.2174/092986710794182962)

2009

Quinn, T.J., and Dawson, J. (2009) Acute `strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5), pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2), pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1), pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1), pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1), pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T. J., and Dawson, J. (2009) Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3), pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6), e468-e468. (doi:10.1161/STROKEAHA.109.551077)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3), pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10), pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

2008

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., and Lees, K.R. (2008) Past, present and future of alteplase for acute ischemic stroke. Expert Review of Neurotherapeutics , 8(2), pp. 181-192. (doi:10.1586/14737175.8.2.181)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2), pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011 )

Christensen, M., Dawson, J., and Vincent, C. (2008) Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Advances in Therapy, 25(9), pp. 831-841. (doi:10.1007/s12325-008-0092-0 )

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1), e9-e9. (doi:10.1161/STROKEAHA.107.502245 )

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5), e89-e89. (doi:10.1161/STROKEAHA.108.515635 )

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2), pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x )

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1), pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11), pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12), pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

2007

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11), e144. (doi:10.1161/STROKEAHA.107.490110)

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6), pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., and Lees, K.R. (2007) Advances in emerging therapies 2006. Stroke, 38(2), pp. 219-221. (doi:10.1161/01.STR.0000254718.22566.90)

Dawson, J., Lees, K.R., and Quinn, T.J. (2007) Acute stroke: we have the treatments and we have the evidence we need to use them. Critical Care Medicine, 11(2), p. 124.

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17), pp. 1879-1886.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8), pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

2004

Briggs, A., Sculpher, M., Dawson, J., Fitzpatrick, R., Murray, D., and Malchau, H. (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3(2), pp. 78-79.

This list was generated on Sat Mar 28 17:33:33 2015 GMT.
Number of items: 66.

Articles

Fulton, R. L., Walters, M. R., Morton, R., Touyz, R. M., Dominiczak, A. F., Morrison, D. S., Padmanabhan, S., Meredith, P. A., McInnes, G. T., and Dawson, J. (2015) Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension, (doi:10.1161/HYPERTENSIONAHA.114.04945) (Early Online Publication)

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J., Macfarlane, P. W., McArthur, K., Langhorne, P., and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi:10.1161/STROKEAHA.114.005405)

Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K.R., Tyrrell, P.J., and Smith, C.J. (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke, 45(2), pp. 520-526. (doi:10.1161/STROKEAHA.113.003433)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9), pp. 563-570. (doi:10.1093/eurheartj/eht539)

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Goodfellow, J.A., Dawson, J., and Quinn, T.J. (2013) Management of blood pressure in acute stroke. Expert Review of Neurotherapeutics, 13(8), pp. 911-923. (doi:10.1586/14737175.2013.814964)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1), pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Ziai, W. C. et al. (2013) A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). International Journal of Stroke, 9(4), pp. 536-542. (doi:10.1111/ijs.12097)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Marshall, S., Fearon, P., Dawson, J., and Quinn, T.J. (2013) Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 13(1), pp. 29-42. (doi:10.1586/ERP.12.79)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7), pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Higgins, P., Macfarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi:10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4), pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5), e35879. (doi:10.1371/journal.pone.0035879)

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6), e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4), pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Dawson, J., and McArthur, K. (2011) Under the weather with stroke before more data emerge - reply. International Journal of Stroke, 6(1), p. 90. (doi:10.1111/j.1747-4949.2010.00546.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi:10.1038/nnano.2011.5)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342, d1938. (doi:10.1136/bmj.d1938)

Stewart, K., Walters, M., and Dawson, J. (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Heart, 97(7), pp. 585-586. (doi:10.1136/hrt.2010.219717)

Harrison, J.K., Sloan, B., Dawson, J., Lees, K.R., and Morrison, D.S. (2010) The ABCD and ABCD2 as predictors of stroke in transient ischemic attack clinic outpatients: a retrospective cohort study over 14 years. Quarterly Journal of Medicine, 103(9), pp. 679-685. (doi:10.1093/qjmed/hcq108)

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3), pp. 18-21.

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2), pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36), pp. 4578-4586. (doi:10.2174/092986710794182962)

Quinn, T.J., and Dawson, J. (2009) Acute `strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5), pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2), pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1), pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1), pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1), pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T. J., and Dawson, J. (2009) Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3), pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6), e468-e468. (doi:10.1161/STROKEAHA.109.551077)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3), pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10), pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., and Lees, K.R. (2008) Past, present and future of alteplase for acute ischemic stroke. Expert Review of Neurotherapeutics , 8(2), pp. 181-192. (doi:10.1586/14737175.8.2.181)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2), pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011 )

Christensen, M., Dawson, J., and Vincent, C. (2008) Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Advances in Therapy, 25(9), pp. 831-841. (doi:10.1007/s12325-008-0092-0 )

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1), e9-e9. (doi:10.1161/STROKEAHA.107.502245 )

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5), e89-e89. (doi:10.1161/STROKEAHA.108.515635 )

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2), pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x )

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1), pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11), pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12), pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11), e144. (doi:10.1161/STROKEAHA.107.490110)

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6), pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., and Lees, K.R. (2007) Advances in emerging therapies 2006. Stroke, 38(2), pp. 219-221. (doi:10.1161/01.STR.0000254718.22566.90)

Dawson, J., Lees, K.R., and Quinn, T.J. (2007) Acute stroke: we have the treatments and we have the evidence we need to use them. Critical Care Medicine, 11(2), p. 124.

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17), pp. 1879-1886.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8), pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

Briggs, A., Sculpher, M., Dawson, J., Fitzpatrick, R., Murray, D., and Malchau, H. (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3(2), pp. 78-79.

Conference Proceedings

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

This list was generated on Sat Mar 28 17:33:33 2015 GMT.